NeuCyte
Neucyte, Inc.: A US-based bio-pharmaceutical firm specializing in cell-based neurological drug discovery.
Founded
2015Neucyte, Inc.: A US-based bio-pharmaceutical firm specializing in cell-based neurological drug discovery.
Founded in San Carlos, CA, NeuCyte, Inc. is a pioneering bio-pharmaceutical company dedicated to developing innovative drugs for neurological diseases. The company’s core mission is to advance the understanding and treatment of neurological disorders through cutting-edge cell-based drug discovery. NeuCyte offers specialized products and services, including their proprietary SynFire® technology, which facilitates long-term functional characterization of induced neurons (iNs) and astrocytes. Their market focus primarily includes pharmaceutical companies and research institutions in the United States.
NeuCyte has garnered attention for its notable team of experts in neuroscience and drug discovery. The company has achieved significant milestones, including the successful application of their SynFire® technology in high-density microelectrode arrays, enhancing the precision and efficacy of neurological drug testing. With a strong emphasis on scientific discovery and innovation, NeuCyte has made a substantial impact on the field of neuropharmacology, contributing valuable insights and tools for the development of treatments for neurological diseases.
Companies similar to NeuCyte include BrainXell, NeyroblastGX, Neurana Pharmaceuticals and Neurovia.
NeuCyte was founded in 2015.
NeuCyte's headquarters is located in Mountain View, CA, US.
NeuCyte's most recent funding round was for $6.7M (USD) in May 2018.
As of May 8, 2018, NeuCyte has disclosed funding of $6.7M (USD). Undisclosed round amounts are excluded.
NeuCyte has 11 employees as of Feb 4, 2024.
Neurovia
